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Protein purification and preparation of crystals AADH was purified from Alcaligenes faecalis IFO 14479 as described (1) . For crystallization, the purified protein was oxidised with 1 mM potassium ferricyanide, exchanged into 10 mM potassium phosphate buffer pH 7.5 by gel exclusion chromatography and concentrated to 20 mg/ml (estimated using an extinction coefficient of 27,600 M -1 cm -1 at 433 nm). Dark-green-coloured crystals of oxidised AADH were produced by the sitting drop vapor diffusion technique using 19-25%
(w/v) PEG 2000 monomethylether, 100 mM ammonium sulphate and 100 mM sodium cacodylate pH 6.0 as a reservoir solution. Crystals (form A) belong to space group P2 1 with unit cell parameters a=70.8, b=89.1, c=80.3 Å, β=90.2° and contain a heterotetramer in the asymmetric unit. Crystals of the phenylhydrazine adduct and tryptamine-reduced AADH were produced by soaking the form A crystals in a stabilising solution that included either 40 mM phenylhydrazine (15 min) or 100 mM tryptamine (3 days). Crystals of the Schiff base and carbinolamine intermediates of AADH were obtained either by soaking of the form A crystals in 100 mM tryptamine solution and flash-cooling immediately after TTQ reduction was observed (crystal turn colourless) or after a period of 5-10 min had passed subsequent to full reduction.
Alternatively, crystal structures were obtained co-crystallization with tryptamine under strict anaerobic conditions. For co-crystallization, the reservoir solution was of a very similar content to that used for oxidised AADH. Protein solution (12.5 mg/ml) was incubated with tryptamine (5 mM) for 15 min and then dialysed anaerobically overnight against 10 mM potassium phosphate, pH 7.5, to remove excess substrate prior to crystallization. Form B crystals (P2 1 2 1 2 1 , a=90.4, b=96.2, c=120.3 Å, one heterotetramer per asymmetric unit) were obtained using 19-21% (w/v) PEG 2K MME; form C crystals (F222, a=119.9, b=157.3, c=268.0 Å, one heterotetramer per asymmetric unit) were obtained using 25-27% PEG 2K MME. Crystals of form B and C were flash-cooled in liquid nitrogen 12 days after setting up the crystallization trials.
Data collection and structure determination
Diffraction data were collected at cryogenic temperatures on ESRF stations ID14-1 and 14-2 (Grenoble, France) and DESY-EMBL station X11 (Hamburg, Germany). All data were processed and scaled using the DENZO/SCALEPACK package (2) ( Table   S3 ). The structure of AADH was determined by the MIR technique using form A crystals. The overall figure of merit of the experimental phase set to 2.3 Å was 0.37. induced radiation damage at the active site was detected and no significant difference could be found as a function of X-ray dose, with the exception of the unavoidable rapid reduction by X-rays of the unsoaked oxidized crystals.
Computational simulations
The tryptamine-derived iminoquinone complex (III), the starting point of all our simulations, was built, following standard procedures with CHARMM, from the 1. PM3/CHARMM22 molecular dynamics simulations were performed for the unrestrained product (IV) and for the complex V generated by proton rearrangement
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MALDI-TOF MS of covalent reduced enzyme intermediate VII
To establish whether intermediate VII is stable in solution, we performed mass spectrometry of the enzyme reduced by substrate.
Material and methods:
MALDI-TOF MS was performed on a Bruker BiFLEX III mass spectrometer operating in linear mode. 1 µL of sample was applied to the MALDI target and allowed to dry. An equal volume of sinapinic acid (10 mg/mL in 60% acetonitrile/40% 0.1%TFA) was added and the solution dried in air. A composite spectrum was constructed resulting from the summation of 20-30 337 nm laser pulses.
The AADH sample comprised 10 µM AADH contained in 20 mM ammonium bicarbonate, pH 7.8. Samples of substrate-reduced AADH were prepared by incubating the enzyme solution with a 4-fold excess of substrate for 15 minutes at room temperature.
Results and discussion:
The mass spectrometry data (Supplementary Data Table SD1) Cross-correlation coefficients from the MM MD simulation for iminoquinone C1/H1 (a,b), Asp128β O1/O2 (c,d) and Thr172β OG1, for motions of the residue centroids (a, c, e) and motions of specific atoms/groups of atoms around the active site (b, d, f). Cross-correlations are shown only for the β-subunit, since no residues from the α-subunit are in contact with C1/H1 or O1/O2, and the substrate indole, which is at the interface between the two subunits, is not significantly correlated with C1/H1 or O1/O2 and is not correlated with motions of the closest residues from the α-subunit (<0.2).
Note: A cross-correlation coefficient of 1 shows perfect correlation. Values close to 1 show a high degree of correlation, e.g.in (b) C1 is highly correlated to H1 (they are bonded). Even when a relatively low cutoff cross-correlation value of 0.5 is used, very little correlation is observed. The rate of reduction of the TTQ centre, which is concerted with C-H/C-D bond cleavage, was measured using stopped-flow methods using an Applied Photophysics SX.18MV
stopped-flow spectrophotometer. Reactions were conducted in 10 mM bis tris propane buffer, pH 7.5 and monitored as absorption bleaching at 456 nm. AADH concentration in the reaction chamber was 1.3 µM; substrate concentration was 180 µM. At least five replica measurements were collected and averaged for each temperature. Analysis of reaction transients was as described (ref. 1). Enzymes were equilibrated for 10 minutes in the stopped-flow apparatus at the appropriate temperature prior to the acquisition of stopped-flow data. The optimal time for equilibration was determined empirically. Temperature control was achieved using a thermostatic circulating water bath and the temperature was monitored directly in the stopped-flow apparatus using a semiconductor sensor. In studies of the temperature dependence of bond cleavage, all substrates were used at saturating concentrations. Studies of the concentration dependence of bond cleavage at each temperature indicated that the apparent enzyme-substrate dissociation constant was not substantially perturbed on changing temperature. These control experiments ensured that substrate was saturating at all the temperatures investigated. 2 The dead time of the stopped-flow instrument was 500 µs. Errors for protiated points at elevated temperatures are larger than those (i) at lower temperature and (ii) for deuterated substrate. This arises owing to the technical; difficulties associated with measuring rate constants > 1000 s -1 by the stopped-flow method. Temperature-dependent rate data can be plotted conveniently using the following form of the Eyring equation:
The enthalpy of activation ∆H ‡ is calculated from the slope of the plot. As discussed previously (ref. 
